Secukinumab versus adalimumab for psoriatic arthritis

被引：0
|
作者：
Thorley, Jennifer
机构：
来源：
LANCET RHEUMATOLOGY | 2020年 / 2卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：E322 / E322
页数：1
相关论文
共 50 条
  • [1] A cost-consequence analysis of the preferential use of secukinumab versus adalimumab for the treatment of psoriatic arthritis
    Jimenez-Morales, Alberto
    Caliz, Rafael
    Aceituno, Susana
    Prades, Miriam
    Blanch, Carles
    [J]. REUMATOLOGIA CLINICA, 2021, 17 (09): : 536 - 542
  • [2] lxekizumab versus adalimumab for psoriatic arthritis
    Thorley, Jennifer
    [J]. LANCET RHEUMATOLOGY, 2020, 2 (09): : E526 - E526
  • [3] Comparative Effectiveness of Adalimumab versus Secukinumab for the Treatment of Psoriatic Arthritis: A Matching-Adjusted Indirect Comparison
    Strand, Vibeke
    Betts, Keith A.
    Mittal, Manish
    Song, Jinlin
    Skup, Martha
    Joshi, Avani
    [J]. RHEUMATOLOGY AND THERAPY, 2017, 4 (02) : 349 - 362
  • [4] Relative Efficacy of Adalimumab Versus Secukinumab in Active Psoriatic Arthritis: A Matching-Adjusted Indirect Comparison
    Betts, Keith A.
    Mittal, Manish
    Joshi, Avani
    Song, Jinlin
    Bao, Yanjun
    [J]. ARTHRITIS & RHEUMATOLOGY, 2015, 67
  • [5] Comparative Effectiveness of Adalimumab versus Secukinumab for the Treatment of Psoriatic Arthritis: A Matching-Adjusted Indirect Comparison
    Vibeke Strand
    Keith A. Betts
    Manish Mittal
    Jinlin Song
    Martha Skup
    Avani Joshi
    [J]. Rheumatology and Therapy, 2017, 4 : 349 - 362
  • [6] Relative efficacy of adalimumab versus secukinumab in active psoriatic arthritis: A matching-adjusted indirect comparison
    Betts, Keith
    Mittal, Manish
    Joshi, Avani
    Song, Jinlin
    Bao, Yanjun
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2016, 74 (05) : AB267 - AB267
  • [7] Tofacitinib or Adalimumab versus Placebo for Psoriatic Arthritis
    Mease, P.
    Hall, S.
    FitzGerald, O.
    van der Heijde, D.
    Merola, J. F.
    Avila-Zapata, F.
    Cieslak, D.
    Graham, D.
    Wang, C.
    Menon, S.
    Hendrikx, T.
    Kanik, K. S.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2017, 377 (16): : 1537 - 1550
  • [8] Ixekizumab versus adalimumab for active psoriatic arthritis
    Thorley, Jennifer
    [J]. LANCET RHEUMATOLOGY, 2019, 1 (03): : E143 - E143
  • [9] Secukinumab for the Treatment of Psoriatic Arthritis: Comparative Effectiveness Versus Adalimumab Using a Matching-Adjusted Indirect Comparison
    Nash, Peter
    McInnes, Iain B.
    Mease, Philip J.
    Choy, Ernest H.
    Thom, Howard
    Kalyvas, Chrysostomos
    Gandhi, Kunal
    Mpofu, Shephard
    Jugl, Steffen
    [J]. ARTHRITIS & RHEUMATOLOGY, 2016, 68
  • [10] Cost per Responder Analysis of Secukinumab versus Adalimumab in the Treatment of Psoriatic Disease
    Gisondi, Paolo
    Geat, Davide
    Maurelli, Martina
    Degli Esposti, Luca
    Bellinato, Francesco
    Girolomoni, Giampiero
    [J]. VACCINES, 2022, 10 (05)
12345